Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Abstral launched in Japan

Dec. 13, 2013

Avanir releases results from phase II PRIME study

Dec. 13, 2013

Scientists at Convergence Pharmaceuticals synthesize new Na(v)1.7 blockers

Dec. 12, 2013

Orion Corp. synthesizes new series of COMT inhibitors

Dec. 12, 2013

French researchers disclose novel mGlu2 receptor modulators

Dec. 12, 2013

Lundbeck and Otsuka set to codevelop Alzheimer's disease vaccine

Dec. 12, 2013

EPOCH study of MK-8931 in Alzheimer's disease to continue after interim safety analysis

Dec. 12, 2013

Roche and Genentech divulge new DLK inhibitors for neurodegenerative disorders

Dec. 11, 2013

Sunovion presents the discovery of novel selective mGlu5 PAMs

Dec. 11, 2013

Novel CB2 agonists demonstrate efficacy in animal models of inflammatory pain

Dec. 11, 2013

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...